Financials
- Market Capitalization 390.54 M
- Employee 59
- Founded 2017
- CEO N/A
- Website www.lexeotx.com
- Headquarter New York, United States
- FIGI BBG00YB1C8M5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3073 | GALT Galectin Therapeutics Inc. - Common Stock | 3.95 USD | -1.74% | +1.02% | +33.00% | -7.71% | 398.36 M USD | ||
| 3076 | LRMR Larimar Therapeutics, Inc. - Common Stock | 3.82 USD | -4.74% | -6.37% | -0.26% | +4.37% | 396.83 M USD | ||
| 3103 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.33 USD | -1.99% | -5.19% | +4.96% | +53.22% | 388.24 M USD | ||
| 3104 | EYPT EyePoint, Inc. - Common Stock | 4.50 USD | +0.45% | -9.64% | -63.53% | -62.50% | 387.95 M USD |